LATEST ALERTS
Talking about the future of the novel nicotine sector in the United States – its biggest single market by a long way – just got a whole lot harder
November will mark ten years since Iqos was launched in Japan. And as the third-quarter results of Philip Morris International show, the last ten years have been quite the story in the product’s global brand-building
Banning popular flavours to discourage youth vaping may jeopardise efforts to curb smoking rates in adults at risk, according to a study published earlier this month in the Journal of the American Medical Association
The use of e-cigarettes among teenagers in the US has hit its lowest level in a decade, as the number of young vapers in the country dropped by half a million in the past year
The US Food and Drug Administration (FDA) has introduced a new rule that increases age restrictions on tobacco and e-cigarette sales, continuing its mission to protect young people from tobacco addiction
Altria Group and its subsidiary Njoy have expressed their disagreement with a recent ruling by the US International Trade Commission (ITC) concerning a patent infringement complaint filed by Juul Labs
Businesses that lead product innovation with what the consumer wants will be one step ahead when it comes to taking a next-generation product to market – particularly when making PMTAs in the US
The US Food and Drug Administration (FDA) and Department of the Treasury have recently proposed a new rule that could significantly impact the importation process for electronic nicotine delivery systems (ENDS) into the country
This report looks at the US concept of the continuum of risk that not all tobacco and nicotine products are equally harmful, traces the evolution of policy based on it over the years, and looks at what has happened to it since
This report analyses the potential impact of recent changes in the “major questions doctrine”, which addresses the issue of how far US federal agencies can go in making policy on their own initiative
All Big Tobacco companies reported growth in their smoke-free segments, reflecting a trend towards diversification from traditional cigarettes, though none have addressed the regulatory environment and its potential impact on future earnings
Altria reported encouraging results for its e-cigarette brand Njoy, as well as rapid expansion of in-store distribution in the second quarter of 2024. It said it strengthened Njoy’s supply chain and tripled its footprint
Lower nicotine content levels make tobacco products less addictive, but in vapes, they may lead users to compensate their intake by increasing the pace and intensity of their puffs, according to a recent study
British American Tobacco reported a drop in first-half revenue, offset by the continued growth of new categories. BAT expects new-category revenue to be weighted in the second half of 2024, driven by phased launches
This report looks at the US federal multi-agency task force to curb the distribution and sale of illegal e-cigarettes, examines options companies have, and summarises the Senate Judiciary Committee hearing on illicit e-cigs
Following the unexpected approval of Njoy’s menthol e-cigarette products, it is no clearer whether the decision by the US Food and Drug Administration was down to science or politics
Our weekly podcast brings you a summary of the ECigIntelligence daily alerts, covering key developments in law and regulation surrounding e-cigarettes and vaping
Reynolds American has launched a new nicotine-free disposable vape that currently doesn’t need to obtain authorisation from the Food and Drug Administration (FDA) to be marketed in the US
There has been jubilation in the US e-cigarette industry over the demise of the legal doctrine of “Chevron deference”, but many outside the sector itself have expressed reservations, and they are right to do so
In this part of a series of articles celebrating the tenth anniversary of Tamarind Intelligence, our editorial director shares ten things he’s learned about the sector in the last decade
The US Supreme Court has overturned the Chevron doctrine, which held that courts should defer to the interpretations of expert federal agencies regarding ambiguous laws the agencies are required to implement
The tobacco industry, public health groups, and the World Health Organization have all recently drawn attention to nicotine analogues – what are these compounds and why the attention?
Our weekly podcast brings you a summary of the ECigIntelligence daily alerts, covering key developments in law and regulation surrounding e-cigarettes and vaping
Public health advocates expressed disappointment after a decision by the US FDA to authorise the sale of several menthol vaping products made by Njoy, including two menthol disposable e-cigarettes
Federal health regulators and law enforcement officials will be working more closely to crack down on the sale of illegal e-cigarettes in the US, including disposable vape products
Our weekly podcast brings you a summary of the ECigIntelligence daily alerts, covering key developments in law and regulation surrounding e-cigarettes and vaping
This report provides analysis of the current regulatory regime for e-cigarettes in the US, covering all aspects from labelling and product restrictions, to retail and advertising regulations
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Submit your access request to explore how it streamlines access to critical market and regulatory insights
"*" indicates required fields
